DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes-Reference-Cited by-同舟云学术

DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes

Published:2012-01 Issue:1-2 Volume:90 Page:21-29
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Kim Mi-Kyung,Chae Yu Na,Kim Ha Dong,Yang Eun Kyoung,Cho Eun Jung,Choi Song-hyen,Cheong Ye-Hwang,Kim Hae-Sun,Kim Heung Jae,Jo Yeong Woo,Son Moon-Ho,Kim Soon-Hoe,Shin Chang Yell

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference44 articles.

1. Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8;Abbott;Eur J Biochem,2000

2. The islet enhancer vildagliptin: mechanisms of improved glucose metabolism;Ahren;Int J Clin Pract,2008

3. Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains;Alfalah;J Biol Chem,2002

4. Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats;Burkey;J Pharmacol Exp Ther,2005

5. Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard;Chen;J Biol Chem,1997

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Evogliptin on the Progression of Aortic Valvular Calcification;Journal of the American College of Cardiology;2024-09

2. Current trends and future directions for the synthesis and pharmacological applications of 2-(2-cyanopyrrolidin-1-yl)-N-3-hydroxyadamantan-1-yl) acetamide (Gliptins);Medicinal Chemistry Research;2024-06-11

3. Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers;Drug Design, Development and Therapy;2022-12

4. Strategies in synthetic design and structure–activity relationship studies of novel heterocyclic scaffolds as aldose reductase‐2 inhibitors;Archiv der Pharmazie;2022-09-20

5. Effects of co-administration of metformin and evogliptin on cerebral infarct volume in the diabetic rat;Experimental Neurology;2022-02